Skip to main content
Premium Trial:

Request an Annual Quote

Taisho Subscribes to Inpharmatica s Biopendium Database

NEW YORK, March 29 (GenomeWeb News) - Inpharmatica has licensed its Biopendium Online genome annotation database to Taisho Pharmaceuticals of Japan, the company said today.

 

Taisho is the third Japanese subscriber to Biopendium, and the first to choose the online version, which was launched last year, according to Inpharmatica, which is based in London.

 

Biopendium, part of Inpharmatica's PharmaCarta chemogenomics platform, contains annotations for 1.4 million sequences from 150 genomes.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more